{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T11:52:51Z","timestamp":1781697171839,"version":"3.54.5"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002744","name":"Bar-Ilan University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002744","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00284-026-04898-y","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:20:38Z","timestamp":1776723638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunomodulatory Strategies for Managing Viral Infections in Solid Organ Transplantation: Progress and Challenges"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7950-0785","authenticated-orcid":false,"given":"Amir","family":"Elalouf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Maoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"4898_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5500\/wjt.v10.i2.29","volume":"10","author":"F Abbas","year":"2020","unstructured":"Abbas F, El Kossi M, Shaheen IS et al (2020) Post-transplantation lymphoproliferative disorders: current concepts and future therapeutic approaches. World J Transplant 10:29\u201346","journal-title":"World J Transplant"},{"key":"4898_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","volume":"148","author":"B Afzali","year":"2007","unstructured":"Afzali B, Lombardi G, Lechler RI, Lord GM (2007) The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 148:32\u201346","journal-title":"Clin Exp Immunol"},{"key":"4898_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41409-019-0548-7","volume":"55","author":"R Al Hamed","year":"2020","unstructured":"Al Hamed R, Bazarbachi AH, Mohty M (2020) Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities. Bone Marrow Transplant 55:25\u201339","journal-title":"Bone Marrow Transplant"},{"key":"4898_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2024.100898","volume":"39","author":"S Alibrandi","year":"2025","unstructured":"Alibrandi S, Clemens A, Chun N (2025) Complement and T cell activation in transplantation. Transplant Rev 39:100898","journal-title":"Transplant Rev"},{"key":"4898_CR5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI160025","volume":"133","author":"S Ando","year":"2023","unstructured":"Ando S, Perkins CM, Sajiki Y et al (2023) mTOR regulates T cell exhaustion and PD-1\u2013targeted immunotherapy response during chronic viral infection. J Clin Invest 133:e160025. https:\/\/doi.org\/10.1172\/JCI160025","journal-title":"J Clin Invest"},{"key":"4898_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2008.02804.x","volume":"124","author":"AN Antoniou","year":"2008","unstructured":"Antoniou AN, Powis SJ (2008) Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway. Immunology 124:1\u201312","journal-title":"Immunology"},{"key":"4898_CR7","unstructured":"April Starinsky (2025) Record 48,000 organ transplants in 2024, yet wait-list grows. In: AdventHealth News Stories. https:\/\/www.adventhealth.com\/news\/record-48000-organ-transplants-2024-yet-waitlist-grows. Accessed 23 Jul 2025"},{"key":"4898_CR8","unstructured":"Arumugham VB, Rayi A (2023) Intravenous immunoglobulin (IVIG). StatPearls"},{"key":"4898_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.787975","volume":"9","author":"R Asleh","year":"2022","unstructured":"Asleh R, Alnsasra H, Habermann TM et al (2022) Post-transplant lymphoproliferative disorder following cardiac transplantation. Front Cardiovasc Med 9:787975","journal-title":"Front Cardiovasc Med"},{"key":"4898_CR10","unstructured":"Avi Nachmani (2025) Heart transplants hit all-time high in Israel for 2024. In: JFeed. https:\/\/www.jfeed.com\/news-israel\/sq0y91. Accessed 23 Jul 2025"},{"key":"4898_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/TI.2026.15781","volume":"39","author":"G Azarfar","year":"2026","unstructured":"Azarfar G, Alotaibi MAM, Sun Y et al (2026) Machine learning\u2013based evaluation of combined EBV and CMV serostatus as predictors of post-transplant lymphoproliferative disorder. Transpl Int 39:15781. https:\/\/doi.org\/10.3389\/TI.2026.15781","journal-title":"Transpl Int"},{"key":"4898_CR12","doi-asserted-by":"crossref","unstructured":"Azevedo LS, Pierrotti LC, Abdala E, et al (2015) Cytomegalovirus infection in transplant recipients. UNIV SAOPAULO","DOI":"10.6061\/clinics\/2015(07)09"},{"key":"4898_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/med.22073","volume":"45","author":"SZ Bahojb Mahdavi","year":"2025","unstructured":"Bahojb Mahdavi SZ, Jebelli A, Aghbash PS et al (2025) A comprehensive overview on the crosstalk between microRNAs and viral pathogenesis and infection. Med Res Rev 45:349\u2013425","journal-title":"Med Res Rev"},{"key":"4898_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.5414\/CP204595","volume":"62","author":"A Bauhofer","year":"2024","unstructured":"Bauhofer A, Balaban \u00dc, Schimo S et al (2024) Adequate IVIG dosing is associated with an improved long-term outcome in secondary immunodeficiency: a prospective, non-interventional study. Int J Clin Pharmacol Ther 62:448\u2013459. https:\/\/doi.org\/10.5414\/CP204595","journal-title":"Int J Clin Pharmacol Ther"},{"key":"4898_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220546","volume":"14","author":"O Beetz","year":"2019","unstructured":"Beetz O, Kolb J, Buck B et al (2019) Recipient natural killer cells alter the course of rejection of allogeneic heart grafts in rats. PLoS ONE 14:e0220546. https:\/\/doi.org\/10.1371\/journal.pone.0220546","journal-title":"PLoS ONE"},{"key":"4898_CR16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2217\/imt.11.2","volume":"3","author":"G Benichou","year":"2011","unstructured":"Benichou G, Yamada Y, Yun SH et al (2011) Immune recognition and rejection of allogeneic skin grafts. Immunotherapy 3:757\u2013770","journal-title":"Immunotherapy"},{"key":"4898_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1270881","volume":"14","author":"JM Benito","year":"2023","unstructured":"Benito JM, Restrepo C, Garc\u00eda-Foncillas J, Rall\u00f3n N (2023) Immune checkpoint inhibitors as potential therapy for reverting T-cell exhaustion and reverting HIV latency in people living with HIV. Front Immunol 14:1270881","journal-title":"Front Immunol"},{"key":"4898_CR18","doi-asserted-by":"crossref","unstructured":"Bhat J, Kabelitz D (2020) An introduction to immunology and epigenetics. In: Epigenetics of the Immune System. BioMed Central Ltd, pp 1\u201323","DOI":"10.1016\/B978-0-12-817964-2.00001-0"},{"key":"4898_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhlto.2023.100047","volume":"4","author":"BS Bisono-Garcia","year":"2024","unstructured":"Bisono-Garcia BS, Yetmar ZA, Nair V et al (2024) Cytomegalovirus infection in heart transplant recipients: epidemiology, risk factors, and long-term outcomes from a major transplant center in the United States. JHLT Open 4:100047. https:\/\/doi.org\/10.1016\/j.jhlto.2023.100047","journal-title":"JHLT Open"},{"key":"4898_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/201754","volume":"2012","author":"OR Blume","year":"2012","unstructured":"Blume OR, Yost SE, Kaplan B (2012) Antibody-mediated rejection: pathogenesis, prevention, treatment, and outcomes. J Transplant 2012:1\u20137. https:\/\/doi.org\/10.1155\/2012\/201754","journal-title":"J Transplant"},{"key":"4898_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00102","volume":"10","author":"M Brillantes","year":"2020","unstructured":"Brillantes M, Beaulieu AM (2020) Memory and memory-like NK cell responses to microbial pathogens. Front Cell Infect Microbiol 10:102","journal-title":"Front Cell Infect Microbiol"},{"key":"4898_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/tid.70042","author":"C Burton","year":"2025","unstructured":"Burton C, Mabilangan C, Preiksaitis J (2025) Incidence and timing of Epstein-Barr Virus whole blood DNAemia in Epstein-Barr Virus-mismatched adult and pediatric solid organ transplant recipients. Transpl Infect Dis. https:\/\/doi.org\/10.1111\/tid.70042","journal-title":"Transpl Infect Dis"},{"key":"4898_CR23","unstructured":"Canadian Institute for Health Information (2025a) Summary statistics on organ transplants, wait-lists and donors. https:\/\/www.cihi.ca\/en\/summary-statistics-on-organ-transplants-wait-lists-and-donors. Accessed 23 Jul 2025"},{"key":"4898_CR24","unstructured":"Canadian Institute for Health Information (2025b) Organ transplants in Canada: Donations and need"},{"key":"4898_CR25","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/TP.0000000000001095","volume":"100","author":"J Carbone","year":"2016","unstructured":"Carbone J (2016) The immunology of posttransplant CMV infection: potential effect of CMV immunoglobulins on distinct components of the immune response to CMV. Transplantation 100:S11\u2013S18. https:\/\/doi.org\/10.1097\/TP.0000000000001095","journal-title":"Transplantation"},{"key":"4898_CR26","doi-asserted-by":"publisher","first-page":"1111328","DOI":"10.3389\/fpsyg.2023.1111328","volume":"14","author":"V Carola","year":"2023","unstructured":"Carola V, Morale C, Vincenzo C et al (2023) Organ donation: psychosocial factors of the decision-making process. Front Psychol 14:1111328","journal-title":"Front Psychol"},{"key":"4898_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.13318","volume":"37","author":"M Chambon","year":"2024","unstructured":"Chambon M, Koenig A (2024) NK cells: not just followers but also initiators of chronic vascular rejection. Transpl Int 37:13318. https:\/\/doi.org\/10.3389\/ti.2024.13318","journal-title":"Transpl Int"},{"key":"4898_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3892\/etm.2014.2104","volume":"9","author":"Y Chen","year":"2015","unstructured":"Chen Y, Fang J, Chen X et al (2015) Effects of the Treg\/Th17 cell balance and their associated cytokines in patients with hepatitis B infection. Exp Ther Med 9:573\u2013578. https:\/\/doi.org\/10.3892\/etm.2014.2104","journal-title":"Exp Ther Med"},{"key":"4898_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/17474086.2023.2176843","volume":"16","author":"F Cinetto","year":"2023","unstructured":"Cinetto F, Francisco IE, Fenchel K et al (2023) Use of immunoglobulin replacement therapy in patients with secondary antibody deficiency in daily practice: a European expert Q&A-based review. Expert Rev Hematol 16:237\u2013243","journal-title":"Expert Rev Hematol"},{"key":"4898_CR30","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1161\/CIR.0000000000000093","volume":"131","author":"MM Colvin","year":"2015","unstructured":"Colvin MM, Cook JL, Chang P et al (2015) Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American heart association: endorsed by the international society for heart and lung transplantation. Circulation 131:1608\u20131639","journal-title":"Circulation"},{"key":"4898_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1147476","volume":"14","author":"A Dagenais","year":"2023","unstructured":"Dagenais A, Villalba-Guerrero C, Olivier M (2023) Trained immunity: a \u201cnew\u201d weapon in the fight against infectious diseases. Front Immunol 14:1147476","journal-title":"Front Immunol"},{"key":"4898_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061914","volume":"15","author":"MG Desimio","year":"2023","unstructured":"Desimio MG, Covino DA, Rivalta B et al (2023) The role of NK cells in EBV infection and related diseases: current understanding and hints for novel therapies. Cancers 15:1914","journal-title":"Cancers"},{"key":"4898_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2024\/5598324","volume":"2024","author":"SW Dong","year":"2024","unstructured":"Dong SW, Blair BM, Alonso CD (2024) Single-center outcomes of Epstein-Barr virus DNAemia in adult solid organ transplant recipients. J Transplant 2024:1\u20137. https:\/\/doi.org\/10.1155\/2024\/5598324","journal-title":"J Transplant"},{"key":"4898_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2023.101798","volume":"77","author":"A Elalouf","year":"2023","unstructured":"Elalouf A (2023) Infections after organ transplantation and immune response. Transpl Immunol 77:101798","journal-title":"Transpl Immunol"},{"key":"4898_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1292625","volume-title":"Modulatory immune responses in fungal infection associated with organ transplant - advancements, management, and challenges","author":"A Elalouf","year":"2023","unstructured":"Elalouf A, Elalouf H, Rosenfeld A (2023) Modulatory immune responses in fungal infection associated with organ transplant - advancements, management, and challenges. Frontiers Media SA"},{"key":"4898_CR36","unstructured":"Elflein J (2024) Organ donations and transplants - Statistics & Facts. In: Statista. https:\/\/www.statista.com\/topics\/2389\/organ-donations-and-transplants\/. Accessed 23 Jul 2025"},{"key":"4898_CR37","unstructured":"Eurotransplant (2025a) Preliminary Eurotransplant annual figures 2025 online. In: Eurotransplant. https:\/\/www.eurotransplant.org\/2025\/01\/30\/preliminary-eurotransplant-annual-figures-2024-online\u202f\/. Accessed 23 Jul 2025"},{"key":"4898_CR38","unstructured":"Eurotransplant (2025b) Eurotransplant - Statistics. In: Eurotransplant Stat. https:\/\/statistics.eurotransplant.org\/index.php?search_type=donors+deceased&. Accessed 23 Jul 2025"},{"key":"4898_CR39","doi-asserted-by":"publisher","first-page":"1523909","DOI":"10.3389\/fmed.2024.1523909","volume":"11","author":"J Feng","year":"2024","unstructured":"Feng J, Zhang X, Tan Z et al (2024) Risk factors and clinical outcomes of cytomegalovirus infection following haploidentical hematopoietic stem cell transplantation in patients with aplastic anemia: a single-center retrospective study. Front Med 11:1523909. https:\/\/doi.org\/10.3389\/fmed.2024.1523909","journal-title":"Front Med"},{"key":"4898_CR40","unstructured":"Fernandez J (2016) Overview of Immunodeficiency Disorders - Immune Disorders - Merck Manuals Consumer Version. In: Merck Man. https:\/\/www.merckmanuals.com\/home\/immune-disorders\/immunodeficiency-disorders\/overview-of-immunodeficiency-disorders"},{"key":"4898_CR41","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/14787210.2022.2013808","volume":"20","author":"P Filippidis","year":"2022","unstructured":"Filippidis P, Vionnet J, Manuel O, Mombelli M (2022) Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review. Expert Rev Anti Infect Ther 20:663\u2013680","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4898_CR42","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ajt.14208","volume":"17","author":"JA Fishman","year":"2017","unstructured":"Fishman JA (2017) Infection in organ transplantation. Am J Transplant 17:856\u2013879. https:\/\/doi.org\/10.1111\/ajt.14208","journal-title":"Am J Transplant"},{"key":"4898_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/cei.12510","volume":"178","author":"DF Florescu","year":"2014","unstructured":"Florescu DF (2014) Solid organ transplantation: hypogammaglobulinaemia and infectious complications after solid organ transplantation. Clin Exp Immunol 178:54\u201356. https:\/\/doi.org\/10.1111\/cei.12510","journal-title":"Clin Exp Immunol"},{"key":"4898_CR44","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1111\/ajt.12401","volume":"13","author":"DF Florescu","year":"2013","unstructured":"Florescu DF, Kalil AC, Qiu F et al (2013) What is the impact of hypogammaglobulinemia on the rate of infections and survival in solid organ transplantation? A meta-analysis. Am J Transplant 13:2601\u20132610. https:\/\/doi.org\/10.1111\/ajt.12401","journal-title":"Am J Transplant"},{"key":"4898_CR45","first-page":"343","volume-title":"Viral Infections After Intestinal Transplantation","author":"DF Florescu","year":"2019","unstructured":"Florescu DF, Sandkovsky U (2019) Viral Infections After Intestinal Transplantation. Springer, Cham, pp 343\u2013368"},{"key":"4898_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.coi.2021.04.003","volume":"72","author":"B Fournier","year":"2021","unstructured":"Fournier B, Latour S (2021) Immunity to EBV as revealed by immunedeficiencies. Curr Opin Immunol 72:107\u2013115","journal-title":"Curr Opin Immunol"},{"key":"4898_CR47","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/MOT.0000000000000771","volume":"25","author":"S Fu","year":"2020","unstructured":"Fu S, Zarrinpar A (2020) Recent advances in precision medicine for individualized immunosuppression. Curr Opin Organ Transplant 25:420\u2013425","journal-title":"Curr Opin Organ Transplant"},{"key":"4898_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1192440","volume":"14","author":"E Gaiffe","year":"2023","unstructured":"Gaiffe E, Colladant M, Desmaret M et al (2023) Pre-transplant immune profile defined by principal component analysis predicts acute rejection after kidney transplantation. Front Immunol 14:1192440. https:\/\/doi.org\/10.3389\/fimmu.2023.1192440","journal-title":"Front Immunol"},{"key":"4898_CR49","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/ckj\/sfac017","volume":"15","author":"I Gandolfini","year":"2022","unstructured":"Gandolfini I, Palmisano A, Fiaccadori E et al (2022) Detecting, preventing and treating non-adherence to immunosuppression after kidney transplantation. Clin Kidney J 15:1253\u20131274","journal-title":"Clin Kidney J"},{"key":"4898_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.977394","volume":"13","author":"Z Gao","year":"2022","unstructured":"Gao Z, Feng Y, Xu J, Liang J (2022) T-cell exhaustion in immune-mediated inflammatory diseases: new implications for immunotherapy. Front Immunol 13:977394","journal-title":"Front Immunol"},{"key":"4898_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/v17101324","author":"AC Garon","year":"2025","unstructured":"Garon AC, Liu Y, Liu F (2025) Congenital Human Cytomegalovirus and the Complement System. Viruses. https:\/\/doi.org\/10.3390\/v17101324","journal-title":"Viruses"},{"key":"4898_CR52","unstructured":"Gupta M, Shorman M (2025) Cytomegalovirus infections. In: Encyclopedia of Infection and Immunity. StatPearls Publishing, pp V2-53-V2-58"},{"key":"4898_CR53","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/cmi.2014.105","volume":"12","author":"A Halenius","year":"2015","unstructured":"Halenius A, Gerke C, Hengel H (2015) Classical and non-classical MHC i molecule manipulation by human cytomegalovirus: so many targets - but how many arrows in the quiver? Cell Mol Immunol 12:139\u2013153","journal-title":"Cell Mol Immunol"},{"key":"4898_CR54","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2491658","volume":"47","author":"S Hidaka","year":"2025","unstructured":"Hidaka S, Tanabe K, Kobayashi S (2025) Incidence of cytomegalovirus infection after kidney transplantation in the modern era of immunosuppression: the VINTAGE study. Ren Fail 47:2491658. https:\/\/doi.org\/10.1080\/0886022X.2025.2491658","journal-title":"Ren Fail"},{"key":"4898_CR55","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1600-6143.2011.03836.x","volume":"12","author":"T Hirohashi","year":"2012","unstructured":"Hirohashi T, Chase CM, Della Pelle P et al (2012) A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant 12:313\u2013321","journal-title":"Am J Transplant"},{"key":"4898_CR56","unstructured":"HRSA | organdonor.gov (2025) Organ Donation Statistics. In: Heal. Resour. Serv. Adm. https:\/\/www.organdonor.gov\/learn\/organ-donation-statistics. Accessed 23 Jul 2025"},{"key":"4898_CR57","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3947\/ic.2024.0016","volume":"56","author":"K Huh","year":"2024","unstructured":"Huh K, Lee SO, Kim J et al (2024) Prevention of cytomegalovirus infection in solid organ transplant recipients: guidelines by the Korean Society of Infectious Diseases and the Korean Society for Transplantation. Infect Chemother 56:101\u2013121. https:\/\/doi.org\/10.3947\/ic.2024.0016","journal-title":"Infect Chemother"},{"key":"4898_CR58","unstructured":"Huq ME, Bhatnagar NK, Hostoffer RW (2023) Hypogammaglobulinemia. StatPearls"},{"key":"4898_CR59","doi-asserted-by":"crossref","unstructured":"Hussain Y, Khan H (2022) Immunosuppressive drugs. In: Encyclopedia of Infection and Immunity. Elsevier, pp 726\u2013740","DOI":"10.1016\/B978-0-12-818731-9.00068-9"},{"key":"4898_CR60","volume":"11","author":"H Iizasa","year":"2020","unstructured":"Iizasa H, Kim H, Kartika AV et al (2020) Role of viral and host microRNAs in immune regulation of Epstein-Barr Virus-associated diseases. Front Immunol 11:502282","journal-title":"Front Immunol"},{"key":"4898_CR61","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02128-16","volume":"91","author":"SE Jackson","year":"2017","unstructured":"Jackson SE, Sedikides GX, Mason GM et al (2017) Human cytomegalovirus (HCMV)-specific CD4 + T cells are polyfunctional and can respond to HCMV-infected dendritic cells in vitro. J Virol 91:e02128-16. https:\/\/doi.org\/10.1128\/jvi.02128-16","journal-title":"J Virol"},{"key":"4898_CR62","doi-asserted-by":"crossref","unstructured":"Kalinski P, Basse P (2019) Immune checkpoint inhibitors. In: Immune Checkpoint Inhibitors in Cancer002E, pp 1\u201317","DOI":"10.1016\/B978-0-323-54948-6.00001-9"},{"key":"4898_CR63","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/v14081616","volume":"14","author":"S Kant","year":"2022","unstructured":"Kant S, Dasgupta A, Bagnasco S, Brennan DC (2022) BK virus nephropathy in kidney transplantation: a state-of-the-art review. Viruses 14:1616","journal-title":"Viruses"},{"key":"4898_CR64","unstructured":"Keidar N (2025) New record in heart transplants in Israel registered in 2024. In: Isr. Natl. News. https:\/\/www.israelnationalnews.com\/news\/402203. Accessed 23 Jul 2025"},{"key":"4898_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01877","volume":"10","author":"K Kildey","year":"2019","unstructured":"Kildey K, Francis RS, Hultin S et al (2019) Specialized roles of human natural killer cell subsets in kidney transplant rejection. Front Immunol 10:460679. https:\/\/doi.org\/10.3389\/fimmu.2019.01877","journal-title":"Front Immunol"},{"key":"4898_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13113-5","volume":"10","author":"A Koenig","year":"2019","unstructured":"Koenig A, Chen CC, Mar\u00e7ais A et al (2019) Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants. Nat Commun 10:1\u201317. https:\/\/doi.org\/10.1038\/s41467-019-13113-5","journal-title":"Nat Commun"},{"key":"4898_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/v16111746","volume":"16","author":"J Koki\u00e7i","year":"2024","unstructured":"Koki\u00e7i J, Preechanukul A, Arellano-Ballestero H et al (2024) Emerging insights into memory natural killer cells and clinical applications. Viruses 16:1746","journal-title":"Viruses"},{"key":"4898_CR68","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40121-022-00746-1","volume":"12","author":"CN Kotton","year":"2023","unstructured":"Kotton CN, Kamar N (2023) New insights on CMV management in solid organ transplant patients: prevention, treatment, and management of resistant\/refractory disease. Infect Dis Ther 12:333\u2013342","journal-title":"Infect Dis Ther"},{"key":"4898_CR69","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/phar.2495","volume":"41","author":"D Kovac","year":"2021","unstructured":"Kovac D, Choe J, Liu E et al (2021) Immunosuppression considerations in simultaneous organ transplant. Pharmacotherapy 41:59\u201376. https:\/\/doi.org\/10.1002\/phar.2495","journal-title":"Pharmacotherapy"},{"key":"4898_CR70","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1007\/s11033-021-06483-x","volume":"48","author":"R Kuan","year":"2021","unstructured":"Kuan R, Agrawal DK, Thankam FG (2021) Treg cells in atherosclerosis. Mol Biol Rep 48:4897\u20134910","journal-title":"Mol Biol Rep"},{"key":"4898_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2023.09.008","volume":"14","author":"N Kumar","year":"2024","unstructured":"Kumar N, Choudhary NS (2024) Managing HBV and HCV infection pre- and post-liver transplant. J Clin Exp Hepatol 14:101287","journal-title":"J Clin Exp Hepatol"},{"key":"4898_CR72","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s40472-022-00362-5","volume":"9","author":"V Kute","year":"2022","unstructured":"Kute V, Meshram HS, Fleetwood VA et al (2022) Solid organ transplantation in sars-cov-2 recovered transplant candidates: a comprehensive review of recent literature. Curr Transplant Rep 9:95\u2013107","journal-title":"Curr Transplant Rep"},{"key":"4898_CR73","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/2643-3230.BCD-23-0049","volume":"4","author":"G Lancman","year":"2023","unstructured":"Lancman G, Parsa K, Kotlarz K et al (2023) IVIg use associated with ten-fold reduction of serious infections in multiple myeloma patients treated with anti-BCMA bispecific antibodies. Blood Cancer Discov 4:440\u2013451. https:\/\/doi.org\/10.1158\/2643-3230.BCD-23-0049","journal-title":"Blood Cancer Discov"},{"key":"4898_CR74","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/pathogens9050353","volume":"9","author":"S\u017d Lepej","year":"2020","unstructured":"Lepej S\u017d, Matuli\u0107 M, Gr\u0161kovi\u0107 P et al (2020) MiRNAs: EBV mechanism for escaping host\u2019s immune response and supporting tumorigenesis. Pathogens 9:353","journal-title":"Pathogens"},{"key":"4898_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01377-9","volume":"8","author":"Q Li","year":"2023","unstructured":"Li Q, Lan P (2023) Activation of immune signals during organ transplantation. Signal Transduct Target Ther 8:1\u201326. https:\/\/doi.org\/10.1038\/s41392-023-01377-9","journal-title":"Signal Transduct Target Ther"},{"key":"4898_CR76","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41408-026-01453-7","volume":"16","author":"T Li","year":"2026","unstructured":"Li T, Wang C, Xiao Q et al (2026) Immune escape mechanisms and therapeutic advances in virus-associated hematological malignancies. Blood Cancer J 16:24","journal-title":"Blood Cancer J"},{"key":"4898_CR77","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/iid3.868","volume":"11","author":"M Liao","year":"2023","unstructured":"Liao M, Wang C, Zhang M, Qiao K (2023) Insight on immune cells in rejection and infection postlung transplant. Immunity Inflamm Dis 11:868","journal-title":"Immunity Inflamm Dis"},{"key":"4898_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00202","volume":"10","author":"EY Lim","year":"2020","unstructured":"Lim EY, Jackson SE, Wills MR (2020) The CD4+ T cell response to human Cytomegalovirus in healthy and immunocompromised people. Front Cell Infect Microbiol 10:202","journal-title":"Front Cell Infect Microbiol"},{"key":"4898_CR79","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/QCO.0000000000000787","volume":"34","author":"J Lindsay","year":"2021","unstructured":"Lindsay J, Othman J, Heldman MR, Slavin MA (2021) Epstein-Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes. Curr Opin Infect Dis 34:635\u2013645","journal-title":"Curr Opin Infect Dis"},{"key":"4898_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/J.JPHA.2024.101150","volume":"15","author":"H Liu","year":"2025","unstructured":"Liu H, Yang W, Jiang J (2025) Targeting tumor metabolism to augment CD8+ T cell anti-tumor immunity. J Pharm Anal 15:101150. https:\/\/doi.org\/10.1016\/J.JPHA.2024.101150","journal-title":"J Pharm Anal"},{"key":"4898_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1041682","volume":"12","author":"J Liu","year":"2022","unstructured":"Liu J, Ji Q, Cheng F et al (2022) The lncRNAs involved in regulating the RIG-I signaling pathway. Front Cell Infect Microbiol 12:1041682","journal-title":"Front Cell Infect Microbiol"},{"key":"4898_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1356869","volume":"15","author":"X Liu","year":"2024","unstructured":"Liu X, Chen L, Peng W et al (2024) Th17\/Treg balance: the bloom and wane in the pathophysiology of sepsis. Front Immunol 15:1356869","journal-title":"Front Immunol"},{"key":"4898_CR83","doi-asserted-by":"publisher","first-page":"183","DOI":"10.5500\/wjt.v10.i7.183","volume":"10","author":"BC Lizaola-Mayo","year":"2020","unstructured":"Lizaola-Mayo BC, Rodriguez EA (2020) Cytomegalovirus infection after liver transplantation. World J Transplant 10:183\u2013190","journal-title":"World J Transplant"},{"key":"4898_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00166","volume":"8","author":"M L\u00f3pez-Botet","year":"2017","unstructured":"L\u00f3pez-Botet M, Vilches C, Redondo-Pach\u00f3n D et al (2017) Dual role of natural killer cells on graft rejection and control of cytomegalovirus infection in renal transplantation. Front Immunol 8:246256","journal-title":"Front Immunol"},{"key":"4898_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/v16071171","volume":"16","author":"E Lujan","year":"2024","unstructured":"Lujan E, Zhang I, Garon AC, Liu F (2024) The interactions of the complement system with human cytomegalovirus. Viruses 16:1171","journal-title":"Viruses"},{"key":"4898_CR86","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1469-0691.12594","volume":"20","author":"C Lumbreras","year":"2014","unstructured":"Lumbreras C, Manuel O, Len O et al (2014) Cytomegalovirus infection in solid organ transplant recipients. Clin Microbiol Infect 20:19\u201326","journal-title":"Clin Microbiol Infect"},{"key":"4898_CR87","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007735","author":"C Ma","year":"2024","unstructured":"Ma C, Chen P, Du J et al (2024) Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2023-007735","journal-title":"J Immunother Cancer"},{"key":"4898_CR88","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3389\/fimmu.2016.00582","volume":"7","author":"J Marino","year":"2016","unstructured":"Marino J, Paster J, Benichou G (2016) Allorecognition by T lymphocytes and allograft rejection. Front Immunol 7:582","journal-title":"Front Immunol"},{"key":"4898_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03391-x","volume":"44","author":"MT Di Martino","year":"2025","unstructured":"Di Martino MT, Tagliaferri P, Tassone P (2025) MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications. J Exp Clin Cancer Res 44:126","journal-title":"J Exp Clin Cancer Res"},{"key":"4898_CR90","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.322","volume":"4","author":"M Mehdizadeh","year":"2021","unstructured":"Mehdizadeh M, Karami S, Ghaffari Nazari H et al (2021) Immunotherapy with adoptive cytomegalovirus-specific T cells transfer: Summarizing latest gene engineering techniques. Heal Sci Rep 4:e322","journal-title":"Heal Sci Rep"},{"key":"4898_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01450","volume":"11","author":"J Mellors","year":"2020","unstructured":"Mellors J, Tipton T, Longet S, Carroll M (2020) Viral evasion of the complement system and its importance for vaccines and therapeutics. Front Immunol 11:1450","journal-title":"Front Immunol"},{"key":"4898_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01282-0","volume":"15","author":"M Mohan","year":"2025","unstructured":"Mohan M, Szabo A, Cheruvalath H et al (2025) Effect of intravenous immunoglobulin (IVIG) supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma. Blood Cancer J 15:74-. https:\/\/doi.org\/10.1038\/s41408-025-01282-0","journal-title":"Blood Cancer J"},{"key":"4898_CR93","unstructured":"Moncloa L (2025) Spain, with over 6,400 transplants, exceeds forecasts for 2024. https:\/\/www.lamoncloa.gob.es\/lang\/en\/gobierno\/news\/paginas\/2025\/20250116-transplant-figures.aspx. Accessed 23 Jul 2025"},{"key":"4898_CR94","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ekir.2019.02.013","volume":"4","author":"JA Moura-Neto","year":"2019","unstructured":"Moura-Neto JA, Braga Silva CA, Moura AF, Rocco Suassuna JH (2019) Emergent arboviruses and renal transplantation: A global challenge. Kidney Int Rep 4:647\u2013655","journal-title":"Kidney Int Rep"},{"key":"4898_CR95","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5500\/wjt.v10.i3.47","volume":"10","author":"A Mrzljak","year":"2020","unstructured":"Mrzljak A, Novak R, Pandak N et al (2020) Emerging and neglected zoonoses in transplant population. World J Transplant 10:47\u201363. https:\/\/doi.org\/10.5500\/wjt.v10.i3.47","journal-title":"World J Transplant"},{"key":"4898_CR96","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.21037\/jtd-2021-24","volume":"13","author":"A Munting","year":"2021","unstructured":"Munting A, Manuel O (2021) Viral infections in lung transplantation. J Thorac Dis 13:6673\u20136694","journal-title":"J Thorac Dis"},{"key":"4898_CR97","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.chom.2013.05.014","volume":"13","author":"CT Ng","year":"2013","unstructured":"Ng CT, Snell LM, Brooks DG, Oldstone MBA (2013) Networking at the level of host immunity: immune cell interactions during persistent viral infections. Cell Host Microbe 13:652\u2013664","journal-title":"Cell Host Microbe"},{"key":"4898_CR98","doi-asserted-by":"crossref","unstructured":"Niehues T (2018) Therapeutic monoclonal antibodies as immunomodulators and anti-cancer agents: Development, evidence of efficacy, mechanisms of actions, adverse effects. In: Antibody Therapy: Substitution - Immunomodulation - Monoclonal Immunotherapy. Springer International Publishing, pp 291\u2013341","DOI":"10.1007\/978-3-319-68038-5_20"},{"key":"4898_CR99","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.3390\/ijms19061750","volume":"19","author":"K N\u00fa\u00f1ez","year":"2018","unstructured":"N\u00fa\u00f1ez K, Thevenot P, Alfadhli A, Cohen A (2018) Complement activation in liver transplantation: role of donor macrosteatosis and implications in delayed graft function. Int J Mol Sci 19:1750","journal-title":"Int J Mol Sci"},{"key":"4898_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.631365","volume":"12","author":"N Oberholtzer","year":"2021","unstructured":"Oberholtzer N, Atkinson C, Nadig SN (2021) Adoptive transfer of regulatory immune cells in organ transplantation. Front Immunol 12:631365","journal-title":"Front Immunol"},{"key":"4898_CR101","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41581-022-00633-5","volume":"19","author":"J Ochando","year":"2023","unstructured":"Ochando J, Mulder WJM, Madsen JC et al (2023) Trained immunity \u2014 basic concepts and contributions to immunopathology. Nat Rev Nephrol 19:23\u201337. https:\/\/doi.org\/10.1038\/s41581-022-00633-5","journal-title":"Nat Rev Nephrol"},{"key":"4898_CR102","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30982","volume":"14","author":"AN Oli","year":"2022","unstructured":"Oli AN, Babajide Rowaiye A, Adejumo SA et al (2022) Classic and current opinions in human organ and tissue transplantation. Cureus 14:e30982. https:\/\/doi.org\/10.7759\/cureus.30982","journal-title":"Cureus"},{"key":"4898_CR103","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/biom12020226","volume":"12","author":"E Ostrycharz","year":"2022","unstructured":"Ostrycharz E, Hukowska-Szematowicz B (2022) New insights into the role of the complement system in human viral diseases. Biomolecules 12:226","journal-title":"Biomolecules"},{"key":"4898_CR104","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3389\/fimmu.2018.00853","volume":"9","author":"A Outlioua","year":"2018","unstructured":"Outlioua A, Pourcelot M, Arnoult D (2018) The role of optineurin in antiviral type I interferon production. Front Immunol 9:853","journal-title":"Front Immunol"},{"key":"4898_CR105","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41573-022-00495-3","volume":"21","author":"G Pantaleo","year":"2022","unstructured":"Pantaleo G, Correia B, Fenwick C et al (2022) Antibodies to combat viral infections: development strategies and progress. Nat Rev Drug Discov 21:676\u2013696","journal-title":"Nat Rev Drug Discov"},{"key":"4898_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103663","volume":"21","author":"KH Park","year":"2020","unstructured":"Park KH, Ryu JH, Bae H et al (2020) Delayed nk cell reconstitution and reduced nk activity increased the risks of cmv disease in allogeneic-hematopoietic stem cell transplantation. Int J Mol Sci 21:3663. https:\/\/doi.org\/10.3390\/ijms21103663","journal-title":"Int J Mol Sci"},{"key":"4898_CR107","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000565","volume":"2","author":"A Pascalev","year":"2016","unstructured":"Pascalev A, Van Assche K, S\u00e1ndor J et al (2016) Protection of human beings trafficked for the purpose of organ removal: recommendations. Transpl Direct 2:E59. https:\/\/doi.org\/10.1097\/TXD.0000000000000565","journal-title":"Transpl Direct"},{"key":"4898_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00033","volume":"10","author":"SY Patel","year":"2019","unstructured":"Patel SY, Carbone J, Jolles S (2019) The expanding field of secondary antibody deficiency: causes, diagnosis, and management. Front Immunol 10:413404","journal-title":"Front Immunol"},{"key":"4898_CR109","doi-asserted-by":"publisher","DOI":"10.1093\/jimmun\/vkaf366","volume":"215","author":"JK Pena","year":"2026","unstructured":"Pena JK, Zhang W, Badshah JS et al (2026) NKG2A+ NK cell cytotoxicity of Epstein-Barr virus infected B cells is mediated through the NKG2D and NKp30 activating receptors. J Immunol 215:vkaf366. https:\/\/doi.org\/10.1093\/jimmun\/vkaf366","journal-title":"J Immunol"},{"key":"4898_CR110","first-page":"353","volume":"38","author":"BL Phillips","year":"2020","unstructured":"Phillips BL, Callaghan C (2020) The immunology of organ transplantation. Surg Infect (Larchmt) 38:353\u2013360","journal-title":"Surg Infect (Larchmt)"},{"key":"4898_CR111","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/phar.2481","volume":"41","author":"NA Pilch","year":"2021","unstructured":"Pilch NA, Bowman LJ, Taber DJ (2021) Immunosuppression trends in solid organ transplantation: the future of individualization, monitoring, and management. Pharmacotherapy 41:119\u2013131","journal-title":"Pharmacotherapy"},{"key":"4898_CR112","first-page":"2624","volume":"117","author":"JS Pober","year":"2021","unstructured":"Pober JS, Chih S, Kobashigawa J et al (2021) Cardiac allograft vasculopathy: current review and future research directions. Cardiovasc Res 117:2624\u20132638","journal-title":"Cardiovasc Res"},{"key":"4898_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01454","volume-title":"The role of natural killer cells in the immune response in kidney transplantation","author":"P Pontrelli","year":"2020","unstructured":"Pontrelli P, Rascio F, Castellano G et al (2020) The role of natural killer cells in the immune response in kidney transplantation. Frontiers Media S.A."},{"key":"4898_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/frtra.2023.1277669","volume":"2","author":"CE Praska","year":"2023","unstructured":"Praska CE, Tamburrini R, Danobeitia JS (2023) Innate immune modulation in transplantation: mechanisms, challenges, and opportunities. Front Transplant 2:1277669. https:\/\/doi.org\/10.3389\/frtra.2023.1277669","journal-title":"Front Transplant"},{"key":"4898_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.848582","volume":"13","author":"D Primorac","year":"2022","unstructured":"Primorac D, Vrdoljak K, Brlek P et al (2022) Adaptive Immune Responses and Immunity to SARS-CoV-2. Front Immunol 13:848582","journal-title":"Front Immunol"},{"key":"4898_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.811696","volume":"13","author":"R Qi","year":"2022","unstructured":"Qi R, Qin W (2022) Role of complement system in kidney transplantation: stepping from animal models to clinical application. Front Immunol 13:811696","journal-title":"Front Immunol"},{"key":"4898_CR117","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","volume":"20","author":"J Rehwinkel","year":"2020","unstructured":"Rehwinkel J, Gack MU (2020) RIG-I-like receptors: their regulation and roles in RNA sensing. Nat Rev Immunol 20:537\u2013551","journal-title":"Nat Rev Immunol"},{"key":"4898_CR118","unstructured":"Richmond V (2025) U.S. surpassed 48,000 organ transplants in 2024 | UNOS. In: United Netw. Organ Shar. https:\/\/unos.org\/media-resources\/releases\/u-s-surpassed-48000-organ-transplants-in-2024\/. Accessed 23 Jul 2025"},{"key":"4898_CR119","doi-asserted-by":"publisher","first-page":"E1302","DOI":"10.1093\/cid\/ciaa1189","volume":"73","author":"MB Roberts","year":"2021","unstructured":"Roberts MB, Fishman JA (2021) Immunosuppressive agents and infectious risk in transplantation: managing the \u201cnet state of immunosuppression.\u201d Clin Infect Dis 73:E1302\u2013E1317. https:\/\/doi.org\/10.1093\/cid\/ciaa1189","journal-title":"Clin Infect Dis"},{"key":"4898_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS18060962","volume":"18","author":"NJ Rueda-Forero","year":"2026","unstructured":"Rueda-Forero NJ, Kluiver J, Koning M et al (2026) Relevance of Epstein-Barr virus (EBV) miRNAs in EBV-infected B cells and B-cell lymphomas. Cancers (Basel) 18:962. https:\/\/doi.org\/10.3390\/CANCERS18060962","journal-title":"Cancers (Basel)"},{"key":"4898_CR121","doi-asserted-by":"publisher","first-page":"52","DOI":"10.5500\/wjt.v5.i2.52","volume":"5","author":"M Salvadori","year":"2015","unstructured":"Salvadori M, Rosso G, Bertoni E (2015) Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment. World J Transplant 5:52. https:\/\/doi.org\/10.5500\/wjt.v5.i2.52","journal-title":"World J Transplant"},{"key":"4898_CR122","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3390\/cells12050791","volume":"12","author":"D Santarsiero","year":"2023","unstructured":"Santarsiero D, Aiello S (2023) The complement system in kidney transplantation. Cells 12:791","journal-title":"Cells"},{"key":"4898_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.70099\/bj\/2025.02.01.1","volume":"2","author":"N Santiago Vispo","year":"2025","unstructured":"Santiago Vispo N (2025) Pioneering the future of organ transplantation: lessons from the Spanish model. Bionatura J 2:1\u20135. https:\/\/doi.org\/10.70099\/bj\/2025.02.01.1","journal-title":"Bionatura J"},{"key":"4898_CR124","doi-asserted-by":"publisher","first-page":"60","DOI":"10.6002\/ect.2024.0307","volume":"23","author":"N Sar\u0131","year":"2025","unstructured":"Sar\u0131 N, Bac\u0131 B, Canl\u0131 MS et al (2025) Unveiling the viral challenges: A 5-year review of infections in solid-organ transplant patients. Exp Clin Transplant 23:60\u201366. https:\/\/doi.org\/10.6002\/ect.2024.0307","journal-title":"Exp Clin Transplant"},{"key":"4898_CR125","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001928","volume":"12","author":"E Sarmiento","year":"2026","unstructured":"Sarmiento E, Montanchez J, Ezzahouri I et al (2026) Evaluation of IVIG for prevention of infections occurring on-study and treatment of infection of solid organ recipients with secondary antibody deficiency: a phase 2 randomized clinical trial. Transpl Direct 12:e1928. https:\/\/doi.org\/10.1097\/TXD.0000000000001928","journal-title":"Transpl Direct"},{"key":"4898_CR126","doi-asserted-by":"publisher","first-page":"582201","DOI":"10.3389\/fimmu.2020.582201","volume":"11","author":"N Scanlon","year":"2020","unstructured":"Scanlon N, Saklawi Y, Rouphael N (2020) The role of systems vaccinology in understanding the immune defects to vaccination in solid organ transplant recipients. Front Immunol 11:582201","journal-title":"Front Immunol"},{"key":"4898_CR127","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s40121-025-01159-6","volume":"14","author":"T Schlaeffer-Yosef","year":"2025","unstructured":"Schlaeffer-Yosef T, Nesher L (2025) Tackling CMV in transplant recipients: past, present, and future. Infect Dis Ther 14:1183\u20131200","journal-title":"Infect Dis Ther"},{"key":"4898_CR128","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/tri.13549","volume":"33","author":"R Schmitz","year":"2020","unstructured":"Schmitz R, Fitch ZW, Schroder PM et al (2020) B cells in transplant tolerance and rejection: friends or foes? Transpl Int 33:30\u201340","journal-title":"Transpl Int"},{"key":"4898_CR129","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1111\/ajt.13684","volume":"16","author":"M Sester","year":"2016","unstructured":"Sester M, Leboeuf C, Schmidt T, Hirsch HH (2016) The \u201cABC\u201d of virus-specific T cell immunity in solid organ transplantation. Am J Transpl 16:1697\u20131706","journal-title":"Am J Transpl"},{"key":"4898_CR130","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.cmi.2025.08.017","volume":"31","author":"T Shafat","year":"2025","unstructured":"Shafat T, Khawaja F, Jiang Y et al (2025) The interplay between Epstein-Barr virus and cytomegalovirus reactivation following allogeneic haematopoietic cell transplantation in the era of primary cytomegalovirus prophylaxis. Clin Microbiol Infect 31:2063\u20132072. https:\/\/doi.org\/10.1016\/j.cmi.2025.08.017","journal-title":"Clin Microbiol Infect"},{"key":"4898_CR131","doi-asserted-by":"crossref","unstructured":"Shah S, Thomas Ginat D (2022) Calcineurin inhibitors. In: Neuroimaging Pharmacopoeia, Second Edition. StatPearls Publishing, pp 173\u2013183","DOI":"10.1007\/978-3-031-08774-5_22"},{"key":"4898_CR132","first-page":"646","volume":"4","author":"S Shahid","year":"2021","unstructured":"Shahid S, Prockop SE (2021) Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: beyond chemotherapy treatment. Cancer Drug Resist 4:646\u2013664","journal-title":"Cancer Drug Resist"},{"key":"4898_CR133","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1097\/TP.0000000000004572","volume":"107","author":"S Short","year":"2023","unstructured":"Short S, Lewik G, Issa F (2023) An immune atlas of T cells in transplant rejection: pathways and therapeutic opportunities. Transplantation 107:2341\u20132352","journal-title":"Transplantation"},{"key":"4898_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.liver.2024.100214","volume":"14","author":"H Sutanto","year":"2024","unstructured":"Sutanto H, Maimunah U, Fetarayani D (2024) Donor-specific antibodies and their impact on antibody-mediated rejection post-liver transplantation: a comprehensive review. J Liver Transpl 14:100214","journal-title":"J Liver Transpl"},{"key":"4898_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2022.991840","volume":"10","author":"D Tan","year":"2022","unstructured":"Tan D, Yin W, Guan F et al (2022) B cell-T cell interplay in immune regulation: a focus on follicular regulatory T and regulatory B cell functions. Front Cell Dev Biol 10:991840. https:\/\/doi.org\/10.3389\/FCELL.2022.991840","journal-title":"Front Cell Dev Biol"},{"key":"4898_CR136","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.ajt.2025.03.005","volume":"25","author":"K Tanaka","year":"2025","unstructured":"Tanaka K, Uchida Y, Kadono K et al (2025) Recipient toll-like receptor 4 determines the outcome of ischemia-reperfusion injury in steatotic liver transplantation in mice. Am J Transpl 25:1168\u20131179. https:\/\/doi.org\/10.1016\/j.ajt.2025.03.005","journal-title":"Am J Transpl"},{"key":"4898_CR137","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00011-022-01651-6","volume":"71","author":"Q Tang","year":"2022","unstructured":"Tang Q, Dong C, Sun Q (2022) Immune response associated with ischemia and reperfusion injury during organ transplantation. Inflamm Res 71:1463\u20131476","journal-title":"Inflamm Res"},{"key":"4898_CR138","unstructured":"Vaillant AAJ, Misra S, Fitzgerald BM (2023) Acute transplantation rejection. StatPearls"},{"key":"4898_CR139","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4625472","volume":"2018","author":"C Vajaitu","year":"2018","unstructured":"Vajaitu C, Draghici CC, Solomon I et al (2018) The central role of inflammation associated with checkpoint inhibitor treatments. J Immunol Res 2018:4625472","journal-title":"J Immunol Res"},{"key":"4898_CR140","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001234","volume":"7","author":"AJ Vinson","year":"2021","unstructured":"Vinson AJ, Agarwal G, Dai R et al (2021) COVID-19 in solid organ transplantation: results of the National COVID cohort collaborative. Transpl Direct 7:e775. https:\/\/doi.org\/10.1097\/TXD.0000000000001234","journal-title":"Transpl Direct"},{"key":"4898_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1146457","volume":"10","author":"KE Vlaming","year":"2023","unstructured":"Vlaming KE, van Wijnbergen K, Kaptein TM et al (2023) Crosstalk between TLR8 and RIG-I-like receptors enhances antiviral immune responses. Front Med 10:1146457. https:\/\/doi.org\/10.3389\/fmed.2023.1146457","journal-title":"Front Med"},{"key":"4898_CR142","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1111\/ajt.16423","volume":"21","author":"LN Walti","year":"2021","unstructured":"Walti LN, Mugglin C, Sidler D et al (2021) Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): a nationwide cohort study. Am J Transpl 21:2532\u20132542. https:\/\/doi.org\/10.1111\/ajt.16423","journal-title":"Am J Transpl"},{"key":"4898_CR143","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/med.22104","volume":"45","author":"J Wang","year":"2025","unstructured":"Wang J, Wang R, Wang M et al (2025) Cutting-edge therapy and immune escape mechanisms in EBV-associated tumors. Med Res Rev 45:1184\u20131210","journal-title":"Med Res Rev"},{"key":"4898_CR144","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1566524023666221118122005","volume":"24","author":"W Wang","year":"2022","unstructured":"Wang W, Yang Y, Zhang Y et al (2022) EBV-microRNAs as potential biomarkers in ebv-related fever: a narrative review. Curr Mol Med 24:2\u201313. https:\/\/doi.org\/10.2174\/1566524023666221118122005","journal-title":"Curr Mol Med"},{"key":"4898_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1418238","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Zhang J, Zhong P, Wei X (2024) Exhaustion of T cells after renal transplantation. Front Immunol 15:1418238","journal-title":"Front Immunol"},{"key":"4898_CR146","volume":"12","author":"J Weng","year":"2023","unstructured":"Weng J, Couture C, Girard S (2023) Innate and adaptive immune systems in physiological and pathological pregnancy. Biol (Basel) 12:402","journal-title":"Biol (Basel)"},{"key":"4898_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413397","volume":"22","author":"K Wicherska\u2010paw\u0142owska","year":"2021","unstructured":"Wicherska\u2010paw\u0142owska K, Wr\u00f3bel T, Rybka J (2021) Toll\u2010like receptors (Tlrs), nod\u2010like receptors (nlrs) and rig\u2010i\u2010like receptors (rlrs) in innate immunity. tlrs, nlrs and rlrs ligands as immunotherapeutic agents for hematopoietic diseases. Int J Mol Sci 22:13397","journal-title":"Int J Mol Sci"},{"key":"4898_CR148","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1161\/CIR.0000000000000456","volume":"134","author":"BS Wiggins","year":"2016","unstructured":"Wiggins BS, Saseen JJ, Page RL et al (2016) Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association. Circulation 134:e468\u2013e495. https:\/\/doi.org\/10.1161\/CIR.0000000000000456","journal-title":"Circulation"},{"key":"4898_CR149","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v14.i3.93209","volume":"14","author":"ZB Yilmaz","year":"2024","unstructured":"Yilmaz ZB, Memisoglu F, Akbulut S (2024) Management of Cytomegalovirus infection after liver transplantation. World J Transpl 14:93209","journal-title":"World J Transpl"},{"key":"4898_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103186","author":"X Zheng","year":"2022","unstructured":"Zheng X, Su R, Hu F et al (2022) Low-dose IL-2 therapy restores imbalance between Th17 and regulatory T cells in patients with the dermatomyositis combined with EBV\/CMV viremia. Autoimmun Rev. https:\/\/doi.org\/10.1016\/j.autrev.2022.103186","journal-title":"Autoimmun Rev"},{"key":"4898_CR151","doi-asserted-by":"publisher","first-page":"589","DOI":"10.15252\/emmm.201607027","volume":"9","author":"H Zhu","year":"2017","unstructured":"Zhu H, Lou F, Yin Q et al (2017) RIG\u2010I antiviral signaling drives interleukin\u201023 production and psoriasis\u2010like skin disease. EMBO Mol Med 9:589\u2013604. https:\/\/doi.org\/10.15252\/emmm.201607027","journal-title":"EMBO Mol Med"},{"key":"4898_CR152","volume":"12","author":"W Zhu","year":"2023","unstructured":"Zhu W, Li Y, Han M, Jiang J (2023) Regulatory mechanisms and reversal of CD8+T cell exhaustion: a literature review. Biology (Basel) 12:541","journal-title":"Biology (Basel)"},{"key":"4898_CR153","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/ajt.12003","volume":"13","author":"RA Zuckerman","year":"2013","unstructured":"Zuckerman RA, Limaye AP (2013) Varicella zoster virus (VZV) and herpes simplex virus (HSV) in solid organ transplant patients. Am J Transplant 13:55\u201366. https:\/\/doi.org\/10.1111\/ajt.12003","journal-title":"Am J Transplant"},{"key":"4898_CR154","unstructured":"(2025a) Organ transplants exceeded 48,000 in 2024; a 3.3 percent increase from the transplants performed in 2023. In: Organ Procure. Transplant. Netw. https:\/\/optn.transplant.hrsa.gov\/news\/organ-transplants-exceeded-48-000-in-2024-a-33-percent-increase-from-the-transplants-performed-in-2023\/. Accessed 23 Jul 2025"},{"key":"4898_CR155","unstructured":"(2025b) Overview of organ donation and transplantation"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04898-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-04898-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04898-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T11:03:33Z","timestamp":1781694213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-026-04898-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":155,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4898"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-04898-y","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}],"article-number":"320"}}